Yarrow Bioscience (YARW) Prepaid Assets (2016 - 2026)
Yarrow Bioscience's (YARW) quarterly Prepaid Assets came in at $861000.0 in Q1 2026, down 81.45% YoY from $4.6 million in Q1 2025, and down 14.07% on a QoQ basis from $1.0 million in Q4 2025.
Yarrow Bioscience (YARW) Prepaid Assets (2016 - 2026) Analysis & Trends
Yarrow Bioscience (YARW) has 11 years of Prepaid Assets data on file, last reported at $861000.0 in Q1 2026.
- Quarterly Prepaid Assets fell 81.45% year-over-year to $861000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $861000.0 (down 81.45% YoY) and the FY2025 annual result came in at $1.0 million, down 65.7% from the prior year.
- Prepaid Assets slipped to $861000.0 in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $5.6 million in Q2 2024 to a low of $861000.0 in Q1 2026.
- A 5-year average of $3.1 million and a median of $3.0 million in 2022 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets soared 178.11% — and 2026, when it slumped 81.45%.
- Tracing YARW's Prepaid Assets over 5 years: stood at $2.3 million in 2022, then rose by 15.48% to $2.7 million in 2023, then increased by 9.98% to $2.9 million in 2024, then tumbled by 65.7% to $1.0 million in 2025, then declined by 14.07% to $861000.0 in 2026.
- The last three Prepaid Assets figures came in at $861000.0 (Q1 2026), $1.0 million (Q4 2025), and $4.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Yarrow Bioscience | 31.25 Mn | 8.33 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 601,000.00 |
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 1.00 Mn |
| Jun 30, 2025 | 4.70 Mn |
| Mar 31, 2025 | 4.64 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 3.30 Mn |
| Jun 30, 2024 | 5.63 Mn |
| Mar 31, 2024 | 4.22 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 2.02 Mn |
| Mar 31, 2023 | 2.64 Mn |
| Dec 31, 2022 | 2.30 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 3.77 Mn |
| Mar 31, 2022 | 3.90 Mn |
| Dec 31, 2021 | 4.57 Mn |
| Sep 30, 2021 | 5.06 Mn |
| Jun 30, 2021 | 5.27 Mn |